157 related articles for article (PubMed ID: 10077140)
1. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
Bronsky E; Ekholm BP; Klinger NM; Colice GL
J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
[TBL] [Abstract][Full Text] [Related]
2. Safety of long-term treatment with HFA albuterol.
Ramsdell JW; Klinger NM; Ekholm BP; Colice GL
Chest; 1999 Apr; 115(4):945-51. PubMed ID: 10208190
[TBL] [Abstract][Full Text] [Related]
3. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
[TBL] [Abstract][Full Text] [Related]
4. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
[TBL] [Abstract][Full Text] [Related]
6. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
Ayres JG; Simmons JL; Stampone P
Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
[TBL] [Abstract][Full Text] [Related]
7. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
Bleecker ER; Tinkelman DG; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
Chest; 1998 Feb; 113(2):283-9. PubMed ID: 9498940
[TBL] [Abstract][Full Text] [Related]
8. Proventil HFA and ventolin have similar safety profiles during regular use.
Tinkelman DG; Bleecker ER; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
Chest; 1998 Feb; 113(2):290-6. PubMed ID: 9498941
[TBL] [Abstract][Full Text] [Related]
9. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
Thompson PJ; Davies RJ; Young WF; Grossman AB; Donnell D
Respir Med; 1998 Jun; 92 Suppl A():33-9. PubMed ID: 9850361
[TBL] [Abstract][Full Text] [Related]
10. The change to non-CFC metered dose inhalers.
Rubinfeld A
Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF; Buist AS
Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group.
Welch M; Bernstein D; Gross G; Kane RE; Banerji D
Chest; 1999 Nov; 116(5):1304-12. PubMed ID: 10559092
[TBL] [Abstract][Full Text] [Related]
13. Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin.
Dockhorn RJ; Wagner DE; Burgess GL; Hafner KB; Letourneau K; Colice GL; Klinger NM
Ann Allergy Asthma Immunol; 1997 Jul; 79(1):85-8. PubMed ID: 9236507
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: a controlled trial.
Blumenthal MN; Casale TB; Fink JN; Uryniak T; Casty FE
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):7-13. PubMed ID: 9449494
[TBL] [Abstract][Full Text] [Related]
15. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ; Stampone P; O'Connor BJ
Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
[TBL] [Abstract][Full Text] [Related]
16. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma.
Kleerup EC; Tashkin DP; Cline AC; Ekholm BP
Chest; 1996 Mar; 109(3):702-7. PubMed ID: 8617079
[TBL] [Abstract][Full Text] [Related]
17. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
Milanowski J; Qualtrough J; Perrin VL
Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
[TBL] [Abstract][Full Text] [Related]
18. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma.
Dockhorn R; Vanden Burgt JA; Ekholm BP; Donnell D; Cullen MT
J Allergy Clin Immunol; 1995 Jul; 96(1):50-6. PubMed ID: 7622763
[TBL] [Abstract][Full Text] [Related]
19. The equivalent bronchodilator effects of salbutamol formulated in chlorofluorocarbon and hydrofluoroalkane-134a metered dose inhalers on the histamine-induced pulmonary response in dogs.
Nogami-Itoh M; Yakuo I; Hammerbeck DM; Miller RL; Takeyama K
Pharm Res; 1997 Feb; 14(2):208-12. PubMed ID: 9090711
[TBL] [Abstract][Full Text] [Related]
20. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
Dahl R; Ringdal N; Ward SM; Stampone P; Donnell D
Br J Clin Pract; 1997; 51(1):11-5. PubMed ID: 9158265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
